Skip to content
Clinical Trials – home
AustriaBack to Austria

Clinical trials in Feldkirch

53 clinical trials in Feldkirch, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Feldkirch at a glance
53
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

53 trials in Feldkirch

Open in trial search
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Medical University Of Graz
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Divarasib
  • Sponsor:F. Hoffmann-La Roche AG
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid
  • Sponsor:Medical University Of Graz
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Genmab A/S
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Other cities in Austria

The busiest research cities in the country

All 47 cities in Austria

Clinical research in Feldkirch

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on multiple myeloma, breast cancer, and lung cancer treatments. Research includes evaluation of novel therapeutic combinations and targeted therapies for various cancer types.

  • Advanced NSCLC Treatments
  • Breast Cancer Therapies
  • Hematologic Malignancies

Several trials are investigating innovative approaches for both early-stage and metastatic diseases.

02 Cardiovascular Studies

Clinical trials examining new treatments for stroke prevention and cardiac conditions. Research includes studies on novel anticoagulants and preventive therapies.

  • Stroke Prevention
  • Post-Heart Attack Care
  • Cardiovascular Risk Management

Focus on reducing major adverse cardiovascular events and improving patient outcomes.

03 Specialty Therapeutics

Innovative research in chronic kidney disease, plaque psoriasis, and other specialized conditions. Studies evaluate both new treatments and improved therapeutic approaches.

  • Autoimmune Conditions
  • Renal Disorders
  • Gastrointestinal Studies

Trials aim to advance treatment options and improve quality of life for patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).